E-drug: Re: Malaria prophylaxis in pregancy (7)
----------------------------------------------------------
Dr Denisa Ionete has taken the discussion a little beyond the original
question, so perhaps I will be forgiven for extending it further. There
was an abstract (see below) from the Geneva Conference on the subject
of malaria and mother-to-child transmission of HIV in Kenya. The
conclusion was:
"...Preliminary results indicate that HIV+ women are at increased risk
for malaria, and placental malaria may increase MCT. A safe,
cost-effective strategy to prevent placental malaria is available and
may reduce MCT in malarious areas..."
First, this clearly supports Dr. Ionete's call for a new paradigm in
addressing the challenge of malaria. But second, can someone shed some
light for a layman on the existing strategy for preventing placental
malaria--this seems somewhat to contradict the earlier discussion.
[Reference: 23268/461 Association between placental malaria infection
and increased risk of mother-to-infant transmission of HIV-1 in western
Kenya
Richard Steketee (1) Bernard Nahlen (2) J. Ayisi (3) A. Van Eijk (3) J.
Otieno (3) A. Misore (3) M. Rayfield (3) K. Udhayakumar (4)
(1) 1600 Clifton road N.E. E46 (CDC) Atlanta Georgia 30333; (2) CDC
DHAP-SE Atlanta GA; (4) CDC Atlanta GA, USA (3) Kenya Medical Research
Institute Kisumu, Kenya]
Chris
----------------------------------
Chris W. Green (chrisg@rad.net.id)
Jakarta, Indonesia
Tel: +62-21 846-3029 Fax: +62-21 846-1247
[Note from moderator: This is an interesting and very important subject as
malaria affects so many, I will therefore let the discussion continue for as
long as new knowledge/information is provided. KM]
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.